Home
Governance
Partners and Advisory Board Countries
Global Expert Steering Group
Partners and Global Advisory Board
Secretariat
Acknowledgements
Partners
Partner Directory
Join
Collaborations
Advocacy and civil society
Commerce and Investment
BSAC/EBRD/Pfizer Inc. alliance
Education
The case for AUC dosing of vancomycin
The case for AUC dosing of vancomycin
Posted on
22 November 2022
(22 November 2022)
by
Neil Watson
Post navigation
Microbiology review for clinicians
Breakpoints: Taking a “BITE” out of antibiotic prescribing: strategies to improve antimicrobial usage in dentistry